R&D DUE DILIGENCE · PAID DISCOVERY™ · EVIDENCE-BASED FORMULATION
The Most Rigorous Supplement Formulation Process in the Industry.
8 Scientific Phases. 13 Elimination Gates. Zero Compromises.
Paid Discovery™ is not a consultation. It is a full-spectrum R&D engagement — from first-principles biochemistry through AI-powered safety verification to production-ready formula architecture. What pharmaceutical companies spend millions on, we deliver for supplement innovators at a fraction of the cost, without a fraction less rigor.
THE PROBLEM WE SOLVE
Why 94% of Supplement Formulations Fail to Deliver Clinical Outcomes.
The supplement industry operates on a broken model. Brands select ingredients from supplier catalogues based on marketing trends, dose them at sub-clinical levels to minimize cost, combine them without understanding pharmacodynamic interactions, and launch products that cannot survive scientific scrutiny. The result: consumer distrust, regulatory enforcement actions, and a market flooded with undifferentiated products competing solely on price.
Paid Discovery™ exists because we refuse to manufacture products designed to fail. Every formula that enters our production facility must first survive the most demanding R&D process available in the supplement CDMO sector. We do not accept briefs. We do not fill capsules with whatever a client requests. We engineer formulations from first principles — starting with the biochemistry of the therapeutic target and working forward through evidence, regulation, safety, and manufacturing physics until we arrive at a composition that is scientifically defensible, legally claimable, and physically producible.
This is not a service we offer alongside manufacturing. It is the mandatory gate through which every product must pass before we agree to produce it. We would rather decline a project than manufacture a formula we cannot defend.
THE EIGHT-PHASE SCIENTIFIC PROCESS
From Molecular Target to Production-Ready Formula.
Each phase is gated. A formula that fails any gate is redesigned or terminated — never forced through. The process is sequential, cumulative, and fully documented.
BIOCHEMICAL ARCHITECTURE
We Begin Where Others End: The Mechanism Map.
Before a single ingredient is considered, our scientific team constructs a complete biochemical mechanism map of the therapeutic target. We identify the relevant signaling pathways, receptor systems, enzymatic cascades, and feedback loops that govern the biological outcome your product must deliver. This is not a literature review — it is a first-principles decomposition of the problem at the molecular level. We map HPA axes, cholinergic systems, mitochondrial electron transport chains, circadian clock genes, and serotonergic pathways with the same rigor applied in pharmaceutical target identification. The mechanism map becomes the constitutional document of your formulation: every ingredient that enters the screening universe must demonstrate a defensible interaction with at least one mapped pathway.
SYSTEMATIC LITERATURE MINING
125 Million Papers. One Proprietary Screening Engine.
Our AI research engine — built in-house and trained on the full corpus of peer-reviewed biomedical literature — performs a systematic search across 125 million indexed publications. It identifies every compound with demonstrated activity on the mapped pathways, extracts dose-response data from randomized controlled trials, flags contradictory findings, and ranks candidates by evidence strength. This is the same methodology described by Forbes as "the algorithm in the capsule" — a system that reads thousands of papers in hours, cross-references findings across disciplines, and surfaces synergistic opportunities that no human team could identify manually. The output is not a list of popular ingredients. It is a universe of 50–100 biochemically justified candidates, each tagged with mechanism of action, effective dose range, and evidence tier.
13-ROUND ELIMINATION FUNNEL
75 Candidates Enter. 17 Survive. The Audit Trail Is Yours.
Every candidate passes through thirteen independent elimination gates — each binary, each documented, each irreversible. Halal compliance. Novel Food status (EU Regulation 2015/2283). UAE Drug Master File registration. SFDA botanical limits. BfR maximum daily intake (Germany). FDA DSHEA/NDI status. Allergen-free verification. Capsule feasibility (density, hygroscopicity, flow). Stability under Zone IVb conditions. Evidence-level threshold (minimum: one human RCT at proposed dose). EU health claim availability (EFSA Article 13/14 register). C-386/23 ruling risk assessment. Cost-feasibility at commercial scale. An ingredient that fails any single gate is eliminated — regardless of how promising its mechanism appears. The full elimination audit trail, with documented rationale for every rejection, is delivered to you as a client-facing Excel workbook. You see every candidate we considered, every gate it passed or failed, and exactly why your final formula contains what it contains.
MULTI-JURISDICTION CLAIMS ENGINEERING
What You Can Legally Say — In Every Market, Simultaneously.
Surviving ingredients are cross-referenced against the regulatory claim databases of every target market. For the EU: the EFSA Register of authorised health claims, including the 15% NRV threshold for vitamins and minerals. For the UAE and Saudi Arabia: SFDA and MoHAP structure/function claim frameworks. For the United States: FDA DSHEA structure/function claim precedents and NDI notification requirements. For Germany specifically: BfR maximum daily intake recommendations that override EU-wide tolerances. We do not treat the GCC as a single regulatory block — Dubai Municipality, SFDA, and UAE federal (EDE) each have distinct requirements. The output is a jurisdiction matrix: for each ingredient, the strongest defensible claim in each market, the exact regulatory condition required to make that claim (e.g., "≥15% NRV per daily dose"), and a risk rating for claims that may be challenged under evolving case law such as C-386/23.
DOSE-MATCHED EVIDENCE VERIFICATION
Every Milligram Justified by a Human Clinical Trial.
For each ingredient in the final formula, we verify that the proposed dose exactly matches — or is directly supported by — the dose used in the pivotal clinical trial demonstrating efficacy. We classify evidence into five tiers: EXACT MATCH (identical dose, identical population, identical endpoint), CLOSE MATCH (dose within ±20%, similar population), SUPPORTED (mechanism confirmed at different dose), MECHANISTIC ONLY (animal/in-vitro data), and COFACTOR (regulatory anchor, not primary active). Ingredients that cannot achieve at least "SUPPORTED" status are removed or repositioned as cofactors with explicit labeling. Every citation includes the DOI, sample size, p-value, and primary endpoint — verifiable by any scientist your team consults. We do not cite reviews of reviews. We cite the trial that tested the dose we use.
AI-POWERED SAFETY & INTERACTION SCREENING
Pharmaceutical-Grade Toxicology. For Every Formula We Release.
Our proprietary AI toxicology model — operating on the same predictive logic used in pharmaceutical drug-drug interaction screening — analyses every formula across five levels of safety assessment. Level 1: individual ingredient NOAEL/UL/ADI verification against EFSA, IOM, and BfR reference values. Level 2: within-formula pharmacodynamic stacking (e.g., serotonergic load, sedation potential, mineral absorption competition). Level 3: cross-product system interactions when multiple SKUs are taken concurrently. Level 4: drug interaction matrix against 9 major medication classes (anticoagulants, SSRIs, MAOIs, benzodiazepines, antihypertensives, diabetes medications, immunosuppressants, antiplatelet agents, pre-surgical protocols). Level 5: market-specific label warning generation (EU conservative standard, UAE/SFDA requirements, US supplement disclaimer). The full interaction matrix ships with every dossier. No other supplement CDMO performs this level of safety verification as standard.
FORMULA ARCHITECTURE & CAPSULE ENGINEERING
Precision Engineering Within Physical Constraints.
The surviving ingredients are assembled into a formula architecture that respects both biochemistry and manufacturing physics. Each ingredient is assigned a role (Core Active, Supporting Active, Claim Anchor, Innovation Layer, Cofactor) with documented removal priority — so you know exactly which ingredient would be sacrificed first if capsule budget is exceeded, and why. Fill weight is calculated against HPMC capsule capacity with 100–150mg excipient headroom reserved. Bulk density estimates account for the specific physical properties of each extract (hygroscopic botanicals vs. dense mineral salts). If the formula does not physically fit in the agreed capsule count — we redesign the architecture, not the science. The result is a Formula Card: exact milligrams, exact branded forms (Cognizin®, affron®, BioPQQ®, TRAACS®), exact role classification, and exact capsule feasibility confirmation.
TRANSPARENT COST MODELLING
You See the Economics Before You Commit to Production.
Before Gate 1 approval, you receive transparent per-unit pricing at multiple production scales — from launch batch through commercial volume. No hidden costs. No surprise upcharges after approval. The COGS model accounts for raw material costs at your specific volume, capsule costs, excipient estimates, waste factors, packaging, and manufacturing overhead. You make the production decision with full economic visibility. If the formula is too expensive at your target retail price — we identify cost optimization paths (alternative forms, dose adjustments within evidence bounds, tier restructuring) without compromising the clinical rationale.
GATE 1 DELIVERABLES
What You Receive Before a Single Capsule Is Filled.
Every Paid Discovery engagement produces a complete scientific and commercial package. You own 100% of the intellectual property. The formula, the data, the audit trail — all yours, unconditionally.
Formulation Dossier
Minimum 15-page scientific document with per-SKU rationale, evidence architecture, regulatory matrix, safety assessment, and COGS estimate.
Formula Card (Excel)
Exact milligrams, branded forms, role classifications, claim status per jurisdiction, dose-match verdicts, and capsule feasibility confirmation.
Full Screening Audit Trail
Complete Excel workbook showing every candidate considered, every elimination gate, every rejection rationale. Proof of the rigor behind your formula.
Toxicology & Interaction Report
5-level safety assessment including drug interaction matrix, cross-SKU system analysis, and market-specific label warning framework.
Jurisdiction Claims Matrix
Per-ingredient, per-market claim availability with regulatory conditions, risk ratings, and exact EFSA/SFDA/FDA claim text.
Evidence Verification Report
Every clinical citation with DOI, sample size, p-value, dose tested, and match verdict. Zero hallucinated references — every claim is independently verifiable.
Direct Encrypted Channel to Your R&D Team
A private, real-time messaging channel embedded in your Client Portal. No tickets, no support queue, no third-party platform. Your messages reach the CEO and Lead Scientist directly — same-day response guaranteed. End-to-end encrypted, ISO 27001 compliant, NDA-protected. Active for the entire duration of your engagement.
AS FEATURED IN FORBES
"The algorithm in the capsule — an AI system that reads thousands of scientific papers, cross-references findings across disciplines, and surfaces synergistic opportunities invisible to human researchers."
— Forbes Poland, Technology Section
Olympia Biosciences maintains a proprietary AI research and safety verification infrastructure — the same class of predictive models used by pharmaceutical companies for drug-drug interaction screening and toxicological risk assessment. Our system performs multi-component matrix kinetics, predictive interaction mapping, and evidence synthesis across the full corpus of indexed biomedical literature.
In the context of Paid Discovery, this infrastructure serves two functions: first, as a research accelerator that identifies evidence patterns across thousands of publications simultaneously; second, as a safety verification layer that mathematically models the interaction profile of every multi-ingredient formula before it reaches production. This is not a marketing claim — it is an operational reality endorsed by the Polish National Centre for Research and Development (NCBR) and documented in peer-reviewed methodology.
The result: formulations that are not merely compliant, but mathematically optimized for bioavailability, safety, and therapeutic coherence. A step no other supplement CDMO takes — because no other supplement CDMO has built the infrastructure to take it.
READY TO BEGIN
Paid Discovery Starts at €2,500 Per SKU.
The fee is credited in full against your first production order. You are not paying for a consultation — you are pre-funding the R&D that makes your product scientifically defensible, regulatorily compliant, and commercially viable across every target market simultaneously.
Paid Discovery is mandatory for all new formulation projects. We do not provide speculative quotes, free scoping, or ingredient lists without completing this process. If your team is not prepared to invest in R&D due diligence, we are not the right partner.
RELATED INTELLIGENCE